← All companies The defensive workbook →
Net-net candidates
Net current asset value: current assets minus every liability, ignoring plant and goodwill. Positive means liquid assets alone could clear all debt with something left for the owner. Whether it trades below that is for the price you bring.
The testNet current asset value (latest annual balance sheet) is positive and at least a tenth of total assets. Ranked by cushion strength.
Graham's practice: he paid no more than about two-thirds of net current asset value, and he held these in wide diversification, dozens at a time, so that no single liquidation had to go well. Each row shows the as-filed components — current assets, total liabilities, diluted shares, the filing year — so the subtraction can be redone by hand.
The price column is yours. Type a price and the row shows it as a percentage of NCAV per share. It is stored only in your browser, per ticker, and it never re-orders or filters the ledger; the list keeps its cushion order no matter what is typed.
Latest annual balance sheets · data as of July 9, 2026.
773 companies showing the strongest 200 by cushion; the other 573 clear the same test
| Company | NCAV / share | Current assets | − Total liabilities | = NCAV | ÷ Diluted shares | Filed | Cushion | Your price | Price / NCAV |
|---|---|---|---|---|---|---|---|---|---|
| NNNN Anbio Biotechnology | $0.69 | $30M | $88K | $30M | 43.7M | 2025 | 100% of assets | $ | — |
| MFI mF International Limited | HK$79.87 | HK$4.0B | HK$26M | HK$4.0B | 50.2M | 2025 | 99% of assets | HK$ | — |
| IMSR Terrestrial Energy Inc. Common Stock | $4.08 | $300M | $8M | $292M | 71.6M | 2025 | 96% of assets | $ | — |
| IMSRW Terrestrial Energy Inc. | $4.08 | $300M | $8M | $292M | 71.6M | 2025 | 96% of assets | $ | — |
| SGMT Sagimet Biosciences Inc. Series A | $3.44 | $116M | $5M | $111M | 32.3M | 2025 | 96% of assets | $ | — |
| UPB Upstream Bio Inc. | $6.22 | $352M | $14M | $338M | 54.3M | 2025 | 95% of assets | $ | — |
| ROMA Roma Green Finance Limited | HK$3.08 | HK$50M | HK$2M | HK$48M | 15.6M | 2025 | 94% of assets | HK$ | — |
| DPRO Draganfly Inc. | C$6.05 | C$100M | C$5M | C$95M | 15.7M | 2025 | 94% of assets | C$ | — |
| MBOT Microbot Medical Inc. | $1.66 | $80M | $4M | $76M | 45.8M | 2025 | 93% of assets | $ | — |
| JANX Janux Therapeutics Inc. | $14.86 | $976M | $45M | $931M | 62.7M | 2025 | 93% of assets | $ | — |
| RR Richtech Robotics Inc. | $1.28 | $256M | $3M | $253M | 197.7M | 2025 | 93% of assets | $ | — |
| RLMD Relmada Therapeutics Inc. | $2.19 | $94M | $7M | $86M | 39.5M | 2025 | 92% of assets | $ | — |
| CD Chaince Digital Holdings Inc. | $0.58 | $45M | $3M | $43M | 73.8M | 2025 | 91% of assets | $ | — |
| CGON CG Oncology Inc. | $8.52 | $759M | $39M | $720M | 84.5M | 2025 | 91% of assets | $ | — |
| QBTS D-Wave Quantum Inc. | $2.27 | $896M | $64M | $833M | 367.5M | 2025 | 91% of assets | $ | — |
| AIOS AIOS Tech Inc. Class A | $0.32 | $5M | $411K | $5M | 14.7M | 2025 | 91% of assets | $ | — |
| ORBS Eightco Holdings Inc. | $0.94 | $245M | $18M | $227M | 240.6M | 2025 | 91% of assets | $ | — |
| WLDSW Wearable Devices Ltd. | $6.28 | $20M | $1M | $18M | 2.9M | 2025 | 91% of assets | $ | — |
| DMAC DiaMedica Therapeutics Inc. | $1.18 | $61M | $5M | $55M | 47.0M | 2025 | 90% of assets | $ | — |
| IMNM Immunome Inc. | $5.41 | $661M | $49M | $612M | 113.1M | 2025 | 90% of assets | $ | — |
| BIOA BioAge Labs Inc. | $6.21 | $287M | $23M | $264M | 42.5M | 2025 | 90% of assets | $ | — |
| RDDT Reddit Inc. | $13.95 | $3.1B | $310M | $2.8B | 202.5M | 2025 | 87% of assets | $ | — |
| MREO Mereo BioPharma Group plc | $0.05 | $45M | $5M | $40M | 801.8M | 2025 | 87% of assets | $ | — |
| NXTT Next Technology Holding Inc. | $51.03 | $524M | $69M | $456M | 8.9M | 2025 | 87% of assets | $ | — |
| DCTH Delcath Systems Inc. | $2.97 | $120M | $12M | $107M | 36.0M | 2025 | 87% of assets | $ | — |
| IMMP Immutep Limited | A$0.09 | A$149M | A$13M | A$136M | 1.46B | 2025 | 86% of assets | A$ | — |
| AVIR Atea Pharmaceuticals Inc. | $3.33 | $311M | $40M | $271M | 81.5M | 2025 | 86% of assets | $ | — |
| LKFT Lakefront Biotherapeutics | €44.14 | €3.1B | €171M | €2.9B | 65.9M | 2025 | 85% of assets | € | — |
| AZ A2Z Cust2Mate Solutions Corp. | $2.33 | $79M | $7M | $72M | 30.9M | 2025 | 85% of assets | $ | — |
| SXTC China SXT Pharmaceuticals Inc. | $321.10 | $35M | $5M | $29M | 92K | 2026 | 85% of assets | $ | — |
| RLAY Relay Therapeutics Inc. | $2.91 | $578M | $54M | $524M | 179.8M | 2025 | 84% of assets | $ | — |
| PROF Profound Medical Corp. | $1.79 | $76M | $11M | $65M | 36.3M | 2025 | 84% of assets | $ | — |
| WRD WeRide Inc. | CN¥6.0B total | CN¥6.6B | CN¥682M | CN¥6.0B | — | 2024 | 83% of assets | no share count | — |
| OSS One Stop Systems Inc. | $1.78 | $51M | $7M | $44M | 24.7M | 2025 | 83% of assets | $ | — |
| UMAC Unusual Machines Inc. | $3.15 | $160M | $8M | $152M | 48.1M | 2025 | 83% of assets | $ | — |
| CBIO Crescent Biopharma Inc. | $7.24 | $237M | $37M | $199M | 27.6M | 2025 | 83% of assets | $ | — |
| ODYS Odysight.ai Inc. | $1.46 | $28M | $4M | $24M | 16.4M | 2025 | 83% of assets | $ | — |
| LWLG Lightwave Logic Inc. | $0.44 | $70M | $5M | $65M | 148.1M | 2025 | 82% of assets | $ | — |
| PRTA Prothena Corporation plc | $4.97 | $315M | $46M | $269M | 54.1M | 2025 | 82% of assets | $ | — |
| CLDX Celldex Therapeutics Inc. | $7.19 | $535M | $56M | $479M | 66.6M | 2025 | 82% of assets | $ | — |
| MPTI M-tron Industries Inc. | $15.69 | $61M | $5M | $56M | 3.6M | 2025 | 82% of assets | $ | — |
| PHOE Phoenix Asia Holdings Limited | $0.36 | $8M | $1M | $7M | 20.0M | 2025 | 82% of assets | $ | — |
| ALMU Aeluma Inc. | $0.00 | $17M | $2M | $16M | 17.35B | 2025 | 82% of assets | $ | — |
| CRNX Crinetics Pharmaceuticals Inc. | $8.78 | $1.0B | $134M | $914M | 104.1M | 2025 | 81% of assets | $ | — |
| STTK Shattuck Labs Inc. | $0.66 | $82M | $9M | $74M | 112.2M | 2025 | 81% of assets | $ | — |
| ABUS Arbutus Biopharma Corporation | $0.39 | $94M | $18M | $76M | 195.2M | 2025 | 81% of assets | $ | — |
| LAES SEALSQ Corp | $3.29 | $450M | $43M | $407M | 123.7M | 2025 | 81% of assets | $ | — |
| NXDR Nextdoor Holdings Inc. | $1.02 | $448M | $56M | $393M | 386.8M | 2025 | 81% of assets | $ | — |
| TUYA Tuya Inc. | $913M total | $1.0B | $110M | $913M | — | 2025 | 81% of assets | no share count | — |
| INMD InMode Ltd. | $9.71 | $699M | $83M | $615M | 63.4M | 2025 | 80% of assets | $ | — |
| BCYC Bicycle Therapeutics plc | $8.26 | $683M | $108M | $575M | 69.7M | 2025 | 80% of assets | $ | — |
| ATOM Atomera Incorporated | $0.48 | $20M | $3M | $17M | 35.3M | 2025 | 80% of assets | $ | — |
| UROY Uranium Royalty Corp. | C$1.87 | C$238M | C$1M | C$237M | 126.8M | 2025 | 80% of assets | C$ | — |
| ALT Altimmune Inc. | $1.79 | $278M | $55M | $223M | 124.5M | 2025 | 80% of assets | $ | — |
| VRDN Viridian Therapeutics Inc. | $7.04 | $894M | $177M | $717M | 101.8M | 2025 | 80% of assets | $ | — |
| YALA Yalla Group Limited | $9.68 | $796M | $86M | $710M | 73.4M | 2025 | 79% of assets | $ | — |
| PHUN Phunware Inc. | $4.74 | $120M | $25M | $96M | 20.2M | 2025 | 79% of assets | $ | — |
| ASMB Assembly Biosciences Inc. | $12.05 | $255M | $51M | $204M | 16.9M | 2025 | 79% of assets | $ | — |
| AMBQ Ambiq Micro Inc. | $7.14 | $168M | $22M | $146M | 20.4M | 2025 | 79% of assets | $ | — |
| PTGX Protagonist Therapeutics Inc. | $7.43 | $578M | $53M | $524M | 70.5M | 2025 | 78% of assets | $ | — |
| ALAB Astera Labs Inc. | $6.59 | $1.4B | $168M | $1.2B | 181.2M | 2025 | 78% of assets | $ | — |
| GRVY GRAVITY CO., LTD. | ₩534.8B total | ₩653.6B | ₩118.8B | ₩534.8B | — | 2024 | 78% of assets | no share count | — |
| OCUL Ocular Therapeutix Inc. | $2.80 | $782M | $154M | $628M | 224.1M | 2025 | 78% of assets | $ | — |
| ACOG Alpha Cognition Inc. | $2.82 | $79M | $17M | $62M | 21.9M | 2025 | 78% of assets | $ | — |
| WVE Wave Life Sciences Ltd. | $2.47 | $615M | $120M | $495M | 200.2M | 2025 | 77% of assets | $ | — |
| MAZE Maze Therapeutics Inc. | $7.16 | $350M | $42M | $308M | 43.0M | 2025 | 77% of assets | $ | — |
| BLSH Bullish | $23.99 | $3.8B | $740M | $3.1B | 127.7M | 2025 | 77% of assets | $ | — |
| CRDO Credo Technology Group Holding Ltd | $9.40 | $2.0B | $232M | $1.8B | 188.2M | 2026 | 77% of assets | $ | — |
| PLTR Palantir Technologies Inc. | $2.66 | $8.4B | $1.5B | $6.8B | 2.57B | 2025 | 77% of assets | $ | — |
| NAMS NewAmsterdam Pharma Company N.V. | $4.85 | $676M | $86M | $590M | 121.7M | 2025 | 77% of assets | $ | — |
| NAMSW NewAmsterdam Pharma Company N.V. | $4.85 | $676M | $86M | $590M | 121.7M | 2025 | 77% of assets | $ | — |
| TNGX Tango Therapeutics Inc. | $2.10 | $354M | $53M | $301M | 143.6M | 2025 | 76% of assets | $ | — |
| SVRA Savara Inc. | $0.86 | $242M | $50M | $191M | 222.4M | 2025 | 75% of assets | $ | — |
| SI Shoulder Innovations Inc. | $6.20 | $157M | $29M | $128M | 20.7M | 2025 | 75% of assets | $ | — |
| CBLL CeriBell Inc. | $3.88 | $187M | $40M | $146M | 37.7M | 2025 | 75% of assets | $ | — |
| EYPT EyePoint Inc. | $3148.55 | $329M | $58M | $271M | 86K | 2025 | 74% of assets | $ | — |
| UZX Linkage Global Inc. | $0.73 | $21M | $5M | $16M | 21.5M | 2025 | 74% of assets | $ | — |
| PLSE Pulse Biosciences Inc Common Stock (DE) | $1.02 | $83M | $14M | $70M | 68.0M | 2025 | 74% of assets | $ | — |
| ACHR Archer Aviation Inc. | $2.36 | $2.1B | $263M | $1.8B | 766.9M | 2025 | 74% of assets | $ | — |
| SMR NuScale Power Corporation | $3.22 | $1.3B | $244M | $1.0B | 319.7M | 2025 | 73% of assets | $ | — |
| RCAT Red Cat Holdings Inc. | $1.65 | $227M | $28M | $199M | 120.8M | 2025 | 73% of assets | $ | — |
| CRSP CRISPR Therapeutics AG | $17.10 | $2.0B | $343M | $1.6B | 96.1M | 2025 | 72% of assets | $ | — |
| FBRX Forte Biosciences Inc. | $4.54 | $81M | $22M | $59M | 12.9M | 2025 | 71% of assets | $ | — |
| CRON Cronos Group Inc. Common Share | $2.20 | $944M | $103M | $841M | 381.8M | 2025 | 70% of assets | $ | — |
| RDCM Radcom Ltd. | $6.13 | $133M | $31M | $102M | 16.6M | 2025 | 70% of assets | $ | — |
| DNTH Dianthus Therapeutics Inc. | $7.74 | $409M | $38M | $372M | 48.0M | 2025 | 70% of assets | $ | — |
| PERF Perfect Corp. Class A Ordinary Share | $1.32 | $173M | $39M | $134M | 101.8M | 2025 | 70% of assets | $ | — |
| ATAI AtaiBeckley Inc. | $0.57 | $276M | $71M | $205M | 357.4M | 2025 | 70% of assets | $ | — |
| ROIV Roivant Sciences Ltd. | $5.74 | $5.2B | $1.2B | $4.0B | 693.9M | 2026 | 70% of assets | $ | — |
| KRNT Kornit Digital Ltd. | $11.93 | $596M | $58M | $538M | 45.1M | 2025 | 70% of assets | $ | — |
| DJCO Daily Journal Corp. (S.C.) | $277.36 | $539M | $157M | $382M | 1.4M | 2025 | 70% of assets | $ | — |
| VEEV Veeva Systems Inc. | $37.55 | $8.0B | $1.8B | $6.2B | 166.0M | 2026 | 69% of assets | $ | — |
| BEAM Beam Therapeutics Inc. | $9.93 | $1.3B | $243M | $1.0B | 103.3M | 2025 | 69% of assets | $ | — |
| HTT High Templar Tech Limited | CN¥118.67 | CN¥11.4B | CN¥2.0B | CN¥9.4B | 79.3M | 2025 | 69% of assets | CN¥ | — |
| TALK Talkspace Inc. | $0.56 | $111M | $18M | $93M | 167.1M | 2025 | 69% of assets | $ | — |
| BBNX Beta Bionics Inc. | $5.10 | $268M | $41M | $227M | 44.4M | 2025 | 69% of assets | $ | — |
| BETA Beta Technologies Inc. | $6.32 | $1.7B | $288M | $1.5B | 229.6M | 2025 | 69% of assets | $ | — |
| NNDM Nano Dimension Ltd. | $2.12 | $526M | $86M | $440M | 207.5M | 2025 | 69% of assets | $ | — |
| QUBT Quantum Computing Inc. | $4.97 | $1.1B | $21M | $1.1B | 224.0M | 2025 | 69% of assets | $ | — |
| DOCS Doximity | $3.88 | $944M | $173M | $771M | 199.0M | 2026 | 69% of assets | $ | — |
| KRYS Krystal Biotech | $29.84 | $1.0B | $114M | $910M | 30.5M | 2025 | 68% of assets | $ | — |
| NSPR InspireMD Inc. | $0.56 | $61M | $14M | $47M | 83.8M | 2025 | 68% of assets | $ | — |
| ARCT Arcturus Therapeutics Holdings Inc. | $6.48 | $241M | $57M | $184M | 28.4M | 2025 | 68% of assets | $ | — |
| PKE Park Aerospace Corp. | $4.62 | $109M | $12M | $96M | 20.9M | 2026 | 68% of assets | $ | — |
| YB Yuanbao Inc. | CN¥29.43 | CN¥4.5B | CN¥1.3B | CN¥3.1B | 107.0M | 2025 | 68% of assets | CN¥ | — |
| CPRX Catalyst Pharmaceuticals Inc. | $5.87 | $894M | $150M | $744M | 126.9M | 2025 | 67% of assets | $ | — |
| ERII Energy Recovery Inc. | $2.96 | $181M | $25M | $156M | 52.7M | 2025 | 67% of assets | $ | — |
| NSSC NAPCO Security Technologies Inc. | $3.70 | $162M | $30M | $133M | 35.9M | 2025 | 67% of assets | $ | — |
| AI C3.ai Inc. | $3.88 | $708M | $163M | $545M | 140.5M | 2026 | 67% of assets | $ | — |
| XZO Exzeo Group Inc. | $2627.63 | $326M | $94M | $232M | 88K | 2025 | 67% of assets | $ | — |
| TSHA Taysha Gene Therapies Inc. | $0.62 | $325M | $96M | $228M | 366.6M | 2025 | 66% of assets | $ | — |
| NRIX Nurix Therapeutics Inc. | $4.14 | $607M | $149M | $457M | 110.6M | 2025 | 66% of assets | $ | — |
| SLGL Sol-Gel Technologies Ltd. | $7.13 | $27M | $7M | $20M | 2.8M | 2025 | 66% of assets | $ | — |
| BMR Beamr Imaging Ltd. Ordinary Share | $0.71 | $12M | $965K | $11M | 15.5M | 2025 | 66% of assets | $ | — |
| PLUT Plutus Financial Group Limited | HK$5.14 | HK$111M | HK$32M | HK$79M | 15.3M | 2025 | 66% of assets | HK$ | — |
| ABEO Abeona Therapeutics Inc. | $2.55 | $205M | $60M | $145M | 56.6M | 2025 | 66% of assets | $ | — |
| SLDB Solid Biosciences Inc. | $1.75 | $205M | $53M | $153M | 87.5M | 2025 | 66% of assets | $ | — |
| CNTB Connect Biopharma Holdings Limited | $0.65 | $51M | $14M | $37M | 56.5M | 2025 | 66% of assets | $ | — |
| AMRN Amarin Corporation plc | $1.05 | $650M | $211M | $438M | 419.1M | 2025 | 65% of assets | $ | — |
| VICR Vicor Corporation | $10.86 | $587M | $74M | $513M | 47.3M | 2025 | 65% of assets | $ | — |
| DSWL Deswell Industries Inc. | $4.92 | $96M | $18M | $78M | 15.9M | 2025 | 65% of assets | $ | — |
| HNST The Honest Company Inc. | $1.30 | $202M | $56M | $147M | 112.8M | 2025 | 65% of assets | $ | — |
| SIBN SI-BONE Inc. | $3.53 | $216M | $61M | $155M | 44.0M | 2025 | 65% of assets | $ | — |
| COGT Cogent Biosciences Inc. | $4.73 | $910M | $301M | $609M | 128.9M | 2025 | 65% of assets | $ | — |
| CV CapsoVision Inc. | $0.25 | $17M | $5M | $12M | 47.5M | 2025 | 65% of assets | $ | — |
| ATGL Alpha Technology Group Limited | HK$1.37 | HK$33M | HK$10M | HK$23M | 16.4M | 2025 | 65% of assets | HK$ | — |
| AGIO Agios Pharmaceuticals Inc. | $14.26 | $942M | $104M | $838M | 58.8M | 2025 | 65% of assets | $ | — |
| OMDA Omada Health Inc. | $3.35 | $273M | $76M | $197M | 58.9M | 2025 | 65% of assets | $ | — |
| BLLN BillionToOne Inc. | $7.69 | $561M | $153M | $408M | 53.0M | 2025 | 64% of assets | $ | — |
| ZH Zhihu Inc. | CN¥56.88 | CN¥4.7B | CN¥1.4B | CN¥3.3B | 58.8M | 2025 | 64% of assets | CN¥ | — |
| BZ KANZHUN LIMITED | CN¥158.05 | CN¥20.4B | CN¥4.5B | CN¥15.8B | 100.1M | 2025 | 64% of assets | CN¥ | — |
| WILC G. Willi-Food International Ltd. | ₪33.31 | ₪528M | ₪65M | ₪463M | 13.9M | 2025 | 64% of assets | ₪ | — |
| ELMD Electromed Inc. | $3.98 | $45M | $11M | $34M | 8.7M | 2025 | 64% of assets | $ | — |
| DBVT DBV Technologies S.A. | $0.35 | $213M | $65M | $148M | 424.6M | 2025 | 63% of assets | $ | — |
| COCO The Vita Coco Company Inc. | $4.83 | $421M | $130M | $292M | 60.5M | 2025 | 63% of assets | $ | — |
| IXHL Incannex Healthcare Inc. | $1.13 | $20M | $7M | $13M | 11.5M | 2025 | 63% of assets | $ | — |
| DGXX Digi Power X Inc. | $1.21 | $95M | $11M | $84M | 69.6M | 2025 | 63% of assets | $ | — |
| SITM SiTime | $30.78 | $949M | $139M | $811M | 26.3M | 2025 | 63% of assets | $ | — |
| FDMT 4D Molecular Therapeutics Inc. | $5.17 | $413M | $61M | $352M | 68.1M | 2025 | 62% of assets | $ | — |
| DAVE Dave Inc. | $20.97 | $437M | $135M | $302M | 14.4M | 2025 | 62% of assets | $ | — |
| LXEO Lexeo Therapeutics Inc. | $3.10 | $188M | $22M | $166M | 53.6M | 2025 | 62% of assets | $ | — |
| AVTX Avalo Therapeutics Inc. | $3.57 | $105M | $33M | $72M | 20.1M | 2025 | 62% of assets | $ | — |
| IRMD iRadimed Corporation | $5.21 | $81M | $14M | $67M | 12.9M | 2025 | 62% of assets | $ | — |
| MDB MongoDB Inc. | $28.30 | $3.1B | $806M | $2.3B | 81.6M | 2026 | 61% of assets | $ | — |
| SERV Serve Robotics Inc. | $2.98 | $241M | $17M | $224M | 75.3M | 2025 | 61% of assets | $ | — |
| CHYM Chime Financial Inc. | $2.98 | $1.8B | $563M | $1.2B | 400.5M | 2025 | 61% of assets | $ | — |
| PRCT PROCEPT BioRobotics Corporation | $5.45 | $450M | $142M | $308M | 56.5M | 2025 | 61% of assets | $ | — |
| CTMX CytomX Therapeutics Inc. | $0.52 | $144M | $53M | $91M | 177.3M | 2025 | 60% of assets | $ | — |
| GDYN Grid Dynamics Holdings Inc. | $4.35 | $440M | $71M | $369M | 84.7M | 2025 | 60% of assets | $ | — |
| CGEN Compugen Ltd. | $1.00 | $148M | $54M | $94M | 94.6M | 2025 | 60% of assets | $ | — |
| PONY Pony AI Inc. | $2.87 | $1.3B | $161M | $1.1B | 379.9M | 2025 | 60% of assets | $ | — |
| RUM Rumble Inc. | $0.78 | $265M | $62M | $203M | 261.1M | 2025 | 60% of assets | $ | — |
| RUMBW Rumble Inc. | $0.78 | $265M | $62M | $203M | 261.1M | 2025 | 60% of assets | $ | — |
| YSXT YSX Tech. Co. Ltd | $1.37 | $54M | $21M | $33M | 24.1M | 2026 | 60% of assets | $ | — |
| CEVA Ceva, Inc. | $8.42 | $285M | $52M | $233M | 27.7M | 2025 | 60% of assets | $ | — |
| HCM HUTCHMED (China) Limited | $1.21 | $1.6B | $515M | $1.1B | 872.9M | 2025 | 60% of assets | $ | — |
| EVMN Evommune Inc. | $3.98 | $153M | $19M | $134M | 33.7M | 2025 | 60% of assets | $ | — |
| USLM United States Lime & Minerals Inc. | $14.08 | $455M | $50M | $405M | 28.8M | 2025 | 59% of assets | $ | — |
| NPK National Presto Industries Inc. | $41551.75 | $403M | $106M | $297M | 7K | 2025 | 59% of assets | $ | — |
| SPHL Springview Holdings Ltd | S$0.55 | S$10M | S$4M | S$6M | 11.5M | 2025 | 59% of assets | S$ | — |
| JOBY Joby Aviation Inc. | $1.12 | $1.4B | $385M | $1.1B | 943.5M | 2025 | 59% of assets | $ | — |
| CTKB Cytek Biosciences Inc. | $2.11 | $392M | $120M | $272M | 128.7M | 2025 | 59% of assets | $ | — |
| ADUR Aduro Clean Technologies Inc. | C$0.25 | C$9M | C$1M | C$8M | 29.6M | 2025 | 59% of assets | C$ | — |
| MRAM Everspin Technologies Inc. | $2.14 | $65M | $16M | $49M | 23.1M | 2025 | 58% of assets | $ | — |
| RSKD Riskified Ltd. | $1.52 | $356M | $116M | $240M | 157.5M | 2025 | 58% of assets | $ | — |
| PSNL Personalis Inc. | $1.87 | $268M | $73M | $195M | 104.2M | 2025 | 58% of assets | $ | — |
| SES SES AI Corporation | $0.48 | $216M | $58M | $158M | 332.8M | 2025 | 58% of assets | $ | — |
| ENLV Enlivex Ltd. | $5.69 | $1.7B | $392M | $1.4B | 237.4M | 2025 | 58% of assets | $ | — |
| ARVN Arvinas Inc. | $6.51 | $701M | $284M | $417M | 64.0M | 2025 | 58% of assets | $ | — |
| CNXN PC Connection Inc. | $30.86 | $1.2B | $441M | $780M | 25.3M | 2025 | 58% of assets | $ | — |
| UTSI UTStarcom Holdings Corp. | $3.50 | $52M | $19M | $32M | 9.2M | 2025 | 58% of assets | $ | — |
| STOK Stoke Therapeutics Inc. | $3.80 | $306M | $66M | $240M | 63.1M | 2025 | 57% of assets | $ | — |
| ABSI Absci Corporation | $0.80 | $150M | $27M | $123M | 153.0M | 2025 | 57% of assets | $ | — |
| MNTN MNTN Inc. | $2.71 | $286M | $73M | $214M | 78.9M | 2025 | 57% of assets | $ | — |
| ATHM Autohome Inc. | CN¥34.38 | CN¥21.2B | CN¥5.3B | CN¥15.9B | 463.0M | 2025 | 56% of assets | CN¥ | — |
| KLIC Kulicke and Soffa Industries Inc. | $11.68 | $902M | $283M | $619M | 53.0M | 2025 | 56% of assets | $ | — |
| MDXG MiMedx Group Inc | $1.29 | $277M | $86M | $191M | 148.4M | 2025 | 56% of assets | $ | — |
| FN Fabrinet | $43.60 | $2.4B | $850M | $1.6B | 36.2M | 2025 | 56% of assets | $ | — |
| QTEX QTREX Quantum Ltd. | $0.17 | $9M | $3M | $6M | 35.9M | 2025 | 56% of assets | $ | — |
| BNR Burning Rock Biotech Limited | CN¥453M total | CN¥739M | CN¥285M | CN¥453M | — | 2025 | 55% of assets | no share count | — |
| APT Alpha Pro Tech Ltd. | $3.96 | $53M | $12M | $41M | 10.3M | 2025 | 55% of assets | $ | — |
| ICG Intchains Group Limited | CN¥4.61 | CN¥603M | CN¥43M | CN¥560M | 121.4M | 2025 | 55% of assets | CN¥ | — |
| LAB Standard BioTools Inc. | $0.80 | $454M | $143M | $311M | 388.2M | 2025 | 55% of assets | $ | — |
| OUST Ouster Inc. | $3.09 | $279M | $88M | $191M | 61.8M | 2025 | 55% of assets | $ | — |
| ZBIO Zenas BioPharma Inc. | $3.77 | $351M | $141M | $210M | 55.6M | 2025 | 55% of assets | $ | — |
| ZM Zoom | $21.67 | $8.7B | $2.2B | $6.5B | 300.2M | 2026 | 54% of assets | $ | — |
| GMHS Gamehaus Holdings Inc. | $0.34 | $40M | $14M | $26M | 75.4M | 2025 | 54% of assets | $ | — |
| XFOR X4 Pharmaceuticals Inc. | $1.25 | $262M | $104M | $157M | 126.3M | 2025 | 54% of assets | $ | — |
| AHMA AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C | $0.29 | $11M | $3M | $8M | 28.3M | 2025 | 54% of assets | $ | — |
| TARS Tarsus Pharmaceuticals Inc. | $7.08 | $523M | $219M | $304M | 43.0M | 2025 | 54% of assets | $ | — |
| NTES NetEase Inc. | CN¥37.43 | CN¥180.6B | CN¥61.1B | CN¥119.5B | 3.19B | 2025 | 54% of assets | CN¥ | — |
| RMBS Rambus | $7.51 | $989M | $165M | $824M | 109.7M | 2025 | 54% of assets | $ | — |
| SNT Senstar Technologies Corporation | $1.26 | $41M | $11M | $29M | 23.3M | 2025 | 54% of assets | $ | — |
| GTLB GitLab Inc. | $5.44 | $1.7B | $732M | $924M | 169.9M | 2026 | 54% of assets | $ | — |
| TWG Top Wealth Group Holding Limited | $0.28 | $17M | $2M | $16M | 56.0M | 2025 | 54% of assets | $ | — |
| COUR Coursera Inc. | $3.16 | $898M | $364M | $534M | 168.7M | 2025 | 53% of assets | $ | — |
| FIGS FIGS Inc. | $1.55 | $447M | $143M | $305M | 196.1M | 2025 | 53% of assets | $ | — |
| TOST Toast Inc. | $2.74 | $2.7B | $1.0B | $1.6B | 602.0M | 2025 | 52% of assets | $ | — |
| IDYA IDEAYA Biosciences Inc. | $6.54 | $667M | $86M | $580M | 88.7M | 2025 | 52% of assets | $ | — |
| KVYO Klaviyo Inc. Series A | $2.69 | $1.2B | $384M | $822M | 305.8M | 2025 | 52% of assets | $ | — |
From the company's SEC filings, computed the same way as on its page. NCAV is current assets minus every liability (total assets less equity), from one coherent annual balance sheet. Typed prices live only in this browser's storage and never leave it; ADR rows report in the filing currency shown, so bring the ordinary-share price in that currency.